Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy
Pediatric Blood & Cancer2016Vol. 63(6), pp. 1086–1090
Citations Over TimeTop 17% of 2016 papers
Sachie Kaneko, Edythe Tham, Mark J. Haykowsky, Maria Spavor, Nee Scze Khoo, Andrew S. Mackie, Jeffrey F. Smallhorn, Richard B. Thompson, Michael D. Nelson
Abstract
Our findings suggest that impaired LV contractility and functional reserve play a role in the reduced exercise capacity in anthracycline cardiotoxicity rather than LV distensibility.
Related Papers
- → Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients(2017)73 cited
- → Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens(2003)6 cited
- Follow-up Study of Children with Anthracycline Cardiotoxicity(2003)
- → Clinical implications of HER-2 and P53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer(2008)
- Expression of TopoisomeraseII(TopoIIα) in Human Breast Carcinoma Tissues and its Relationship with Anthracycline Sensitivity(2013)